The primary aim is to compare the effectiveness of intradetrusor injection of 100 unit
injection of Botulinum toxin A to mid-urethral sling for change in MUI symptoms 6 months
following treatment.
Phase:
Phase 3
Details
Lead Sponsor:
NICHD Pelvic Floor Disorders Network
Collaborators:
Duke University Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Kaiser Permanente RTI International University of Alabama at Birmingham University of California, San Diego University of Pennsylvania University of Pittsburgh University of Texas Southwestern Medical Center Women and Infants Hospital of Rhode Island
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A